Hemoglobin-based blood substitutes and the hazards of blood radicals

Cell-free hemoglobins, chemically altered or genetically expressed in microbial host systems, have been developed as oxygen-carrying therapeutics. Sitedirected modifications are introduced and serve to stabilize the protein molecules in a tetrameric and/or a polymeric functional form. Animal studies...

Full description

Saved in:
Bibliographic Details
Published in:Free radical research 2000-01, Vol.33 (4), p.341-348
Main Author: Alayash, Abdu I.
Format: Article
Language:English
Subjects:
Animals
Blood Substitutes
Free Radicals
Hemoglobins - adverse effects
Humans
Nitric Oxide - metabolism
Oxidation-Reduction
Recombinant Proteins - adverse effects
Solutions
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c402t-6b84c4e9e6d98c73c0d9d6239d8ff980baf8739c3266db838e339e17b37de72c3
cites cdi_FETCH-LOGICAL-c402t-6b84c4e9e6d98c73c0d9d6239d8ff980baf8739c3266db838e339e17b37de72c3
container_end_page 348
container_issue 4
container_start_page 341
container_title Free radical research
container_volume 33
creator Alayash, Abdu I.
description Cell-free hemoglobins, chemically altered or genetically expressed in microbial host systems, have been developed as oxygen-carrying therapeutics. Sitedirected modifications are introduced and serve to stabilize the protein molecules in a tetrameric and/or a polymeric functional form. Animal studies, as well as recent clinical studies, have suggested these proteins probably deliver oxygen to tissues. However, concerns still persist regarding the interference of hemoglobin and its oxidation products with the vascular redox balance, potentially impeding its clinical usefulness. This article reviews our current understanding of heme-mediated toxicities and some of the emerging protective strategies used to overcome hemoglobin side reactions.
doi_str_mv 10.1080/10715760000300881
format article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmed_primary_11022843</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>11022843</sourcerecordid><originalsourceid>FETCH-LOGICAL-c402t-6b84c4e9e6d98c73c0d9d6239d8ff980baf8739c3266db838e339e17b37de72c3</originalsourceid><addsrcrecordid>eNp9kF1LwzAUhoMobk5_gDfSP1A9SbomQW9kfsLAG70u-bQdbTOSFpm_3owNRISdm_dcPO_h8CB0ieEaA4cbDAzPWQlpKADn-AhNMRCRk4LB8XZnOE8AmaCzGFcAmBZzdoomOFGEF3SKHl5s5z9br5o-VzJak6nWe5PFUcWhGcbBxkz2Jhtqm9XyWwYTM-_2UJCm0bKN5-jEpbAX-5yhj6fH98VLvnx7fl3cL3NdABnyUvFCF1bY0giuGdVghCkJFYY7Jzgo6TijQlNSlkZxyi2lwmKmKDOWEU1nCO_u6uBjDNZV69B0MmwqDNXWSPXPSOpc7TrrUXXW_Db2ChJwtwOa3vnQyS8fWlMNctP64ILsdRMreuj-7Z96bWU71FoGW638GPrk48B3P-uigHE</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Hemoglobin-based blood substitutes and the hazards of blood radicals</title><source>Taylor and Francis Science and Technology Collection</source><creator>Alayash, Abdu I.</creator><creatorcontrib>Alayash, Abdu I.</creatorcontrib><description>Cell-free hemoglobins, chemically altered or genetically expressed in microbial host systems, have been developed as oxygen-carrying therapeutics. Sitedirected modifications are introduced and serve to stabilize the protein molecules in a tetrameric and/or a polymeric functional form. Animal studies, as well as recent clinical studies, have suggested these proteins probably deliver oxygen to tissues. However, concerns still persist regarding the interference of hemoglobin and its oxidation products with the vascular redox balance, potentially impeding its clinical usefulness. This article reviews our current understanding of heme-mediated toxicities and some of the emerging protective strategies used to overcome hemoglobin side reactions.</description><identifier>ISSN: 1071-5762</identifier><identifier>EISSN: 1029-2470</identifier><identifier>DOI: 10.1080/10715760000300881</identifier><identifier>PMID: 11022843</identifier><language>eng</language><publisher>England: Informa UK Ltd</publisher><subject>Animals ; Blood Substitutes ; Free Radicals ; Hemoglobins - adverse effects ; Humans ; Nitric Oxide - metabolism ; Oxidation-Reduction ; Recombinant Proteins - adverse effects ; Solutions</subject><ispartof>Free radical research, 2000-01, Vol.33 (4), p.341-348</ispartof><rights>2000 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 2000</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c402t-6b84c4e9e6d98c73c0d9d6239d8ff980baf8739c3266db838e339e17b37de72c3</citedby><cites>FETCH-LOGICAL-c402t-6b84c4e9e6d98c73c0d9d6239d8ff980baf8739c3266db838e339e17b37de72c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11022843$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Alayash, Abdu I.</creatorcontrib><title>Hemoglobin-based blood substitutes and the hazards of blood radicals</title><title>Free radical research</title><addtitle>Free Radic Res</addtitle><description>Cell-free hemoglobins, chemically altered or genetically expressed in microbial host systems, have been developed as oxygen-carrying therapeutics. Sitedirected modifications are introduced and serve to stabilize the protein molecules in a tetrameric and/or a polymeric functional form. Animal studies, as well as recent clinical studies, have suggested these proteins probably deliver oxygen to tissues. However, concerns still persist regarding the interference of hemoglobin and its oxidation products with the vascular redox balance, potentially impeding its clinical usefulness. This article reviews our current understanding of heme-mediated toxicities and some of the emerging protective strategies used to overcome hemoglobin side reactions.</description><subject>Animals</subject><subject>Blood Substitutes</subject><subject>Free Radicals</subject><subject>Hemoglobins - adverse effects</subject><subject>Humans</subject><subject>Nitric Oxide - metabolism</subject><subject>Oxidation-Reduction</subject><subject>Recombinant Proteins - adverse effects</subject><subject>Solutions</subject><issn>1071-5762</issn><issn>1029-2470</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><recordid>eNp9kF1LwzAUhoMobk5_gDfSP1A9SbomQW9kfsLAG70u-bQdbTOSFpm_3owNRISdm_dcPO_h8CB0ieEaA4cbDAzPWQlpKADn-AhNMRCRk4LB8XZnOE8AmaCzGFcAmBZzdoomOFGEF3SKHl5s5z9br5o-VzJak6nWe5PFUcWhGcbBxkz2Jhtqm9XyWwYTM-_2UJCm0bKN5-jEpbAX-5yhj6fH98VLvnx7fl3cL3NdABnyUvFCF1bY0giuGdVghCkJFYY7Jzgo6TijQlNSlkZxyi2lwmKmKDOWEU1nCO_u6uBjDNZV69B0MmwqDNXWSPXPSOpc7TrrUXXW_Db2ChJwtwOa3vnQyS8fWlMNctP64ILsdRMreuj-7Z96bWU71FoGW638GPrk48B3P-uigHE</recordid><startdate>20000101</startdate><enddate>20000101</enddate><creator>Alayash, Abdu I.</creator><general>Informa UK Ltd</general><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>20000101</creationdate><title>Hemoglobin-based blood substitutes and the hazards of blood radicals</title><author>Alayash, Abdu I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c402t-6b84c4e9e6d98c73c0d9d6239d8ff980baf8739c3266db838e339e17b37de72c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Animals</topic><topic>Blood Substitutes</topic><topic>Free Radicals</topic><topic>Hemoglobins - adverse effects</topic><topic>Humans</topic><topic>Nitric Oxide - metabolism</topic><topic>Oxidation-Reduction</topic><topic>Recombinant Proteins - adverse effects</topic><topic>Solutions</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Alayash, Abdu I.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Free radical research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Alayash, Abdu I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hemoglobin-based blood substitutes and the hazards of blood radicals</atitle><jtitle>Free radical research</jtitle><addtitle>Free Radic Res</addtitle><date>2000-01-01</date><risdate>2000</risdate><volume>33</volume><issue>4</issue><spage>341</spage><epage>348</epage><pages>341-348</pages><issn>1071-5762</issn><eissn>1029-2470</eissn><abstract>Cell-free hemoglobins, chemically altered or genetically expressed in microbial host systems, have been developed as oxygen-carrying therapeutics. Sitedirected modifications are introduced and serve to stabilize the protein molecules in a tetrameric and/or a polymeric functional form. Animal studies, as well as recent clinical studies, have suggested these proteins probably deliver oxygen to tissues. However, concerns still persist regarding the interference of hemoglobin and its oxidation products with the vascular redox balance, potentially impeding its clinical usefulness. This article reviews our current understanding of heme-mediated toxicities and some of the emerging protective strategies used to overcome hemoglobin side reactions.</abstract><cop>England</cop><pub>Informa UK Ltd</pub><pmid>11022843</pmid><doi>10.1080/10715760000300881</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1071-5762
ispartof Free radical research, 2000-01, Vol.33 (4), p.341-348
issn 1071-5762
1029-2470
language eng
recordid cdi_pubmed_primary_11022843
source Taylor and Francis Science and Technology Collection
subjects Animals
Blood Substitutes
Free Radicals
Hemoglobins - adverse effects
Humans
Nitric Oxide - metabolism
Oxidation-Reduction
Recombinant Proteins - adverse effects
Solutions
title Hemoglobin-based blood substitutes and the hazards of blood radicals
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T07%3A44%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hemoglobin-based%20blood%20substitutes%20and%20the%20hazards%20of%20blood%20radicals&rft.jtitle=Free%20radical%20research&rft.au=Alayash,%20Abdu%20I.&rft.date=2000-01-01&rft.volume=33&rft.issue=4&rft.spage=341&rft.epage=348&rft.pages=341-348&rft.issn=1071-5762&rft.eissn=1029-2470&rft_id=info:doi/10.1080/10715760000300881&rft_dat=%3Cpubmed_cross%3E11022843%3C/pubmed_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c402t-6b84c4e9e6d98c73c0d9d6239d8ff980baf8739c3266db838e339e17b37de72c3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/11022843&rfr_iscdi=true